This chemical is primarily used in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of drugs that target specific biological pathways, often in the treatment of metabolic and neurological disorders. Its trifluoroethoxy group enhances the stability and bioavailability of the resulting drug molecules, making it valuable in medicinal chemistry. Additionally, it is utilized in research settings for the development of novel therapeutic agents, especially in the field of organic synthesis and drug discovery.